Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra Amor

Showing results (21-30 of 148) with videos related to

Pageof 15
Sort By:
CNS & Neurological Disorders Drug Targets|May 16, 2012
Mechanisms in the development of multiple sclerosis lesions: reconciling autoimmune and neurodegenerative factorsJohannes M van Noort, David Baker, Sandra Amor
CNS & Neurological Disorders Drug Targets|April 10, 2012
Multiple sclerosis update: hot topics from 5th joint triennial congress of the European and Americas Committees for Treatment and Research in Multiple Sclerosis (ECTRIMS/ACTRIMS)Daphne Vogel, Baukje van der Star, Sandra Amor
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 5, 2011
Critical appraisal of animal models of multiple sclerosisDavid Baker, Wouter Gerritsen, Jon Rundle, et al.
CNS & Neurological Disorders Drug Targets|May 16, 2012
Pathology of multiple sclerosisMarkus Kipp, Paul van der Valk, Sandra Amor
Nature|December 11, 2012
Reproducibility: Research-reporting standards fall shortDavid Baker, Katie Lidster, Ana Sottomayor, et al.
Plos Biology|January 11, 2014
Two years later: journals are not yet enforcing the ARRIVE guidelines on reporting standards for pre-clinical animal studiesDavid Baker, Katie Lidster, Ana Sottomayor, et al.
Frontiers in Neuroendocrinology|February 1, 2012
Multiple sclerosis: neuroprotective alliance of estrogen-progesterone and genderMarkus Kipp, Sandra Amor, Raphael Krauth, et al.
Drug Discovery Today|June 9, 2004
Evaluating the validity of animal models for research into therapies for immune-based disordersBert A 't Hart, Sandra Amor, Margreet Jonker
Multiple Sclerosis and Related Disorders|September 21, 2016
CD20 therapies in multiple sclerosis and experimental autoimmune encephalomyelitis - Targeting T or B cells?Marie Colombe Agahozo, Laura Peferoen, David Baker, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2011
Comment on "Chaperone activity of α B-crystallin is responsible for its incorrect assignment as an autoantigen in multiple sclerosis"Johannes M van Noort, Sandra Amor, Jeffrey J Bajramovic
Pageof 15

Showing results (21-30 of 148) with videos related to

Sort By:
Pageof 15
CNS & Neurological Disorders Drug Targets|May 16, 2012
Mechanisms in the development of multiple sclerosis lesions: reconciling autoimmune and neurodegenerative factorsJohannes M van Noort, David Baker, Sandra Amor
CNS & Neurological Disorders Drug Targets|April 10, 2012
Multiple sclerosis update: hot topics from 5th joint triennial congress of the European and Americas Committees for Treatment and Research in Multiple Sclerosis (ECTRIMS/ACTRIMS)Daphne Vogel, Baukje van der Star, Sandra Amor
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 5, 2011
Critical appraisal of animal models of multiple sclerosisDavid Baker, Wouter Gerritsen, Jon Rundle, et al.
CNS & Neurological Disorders Drug Targets|May 16, 2012
Pathology of multiple sclerosisMarkus Kipp, Paul van der Valk, Sandra Amor
Nature|December 11, 2012
Reproducibility: Research-reporting standards fall shortDavid Baker, Katie Lidster, Ana Sottomayor, et al.
Plos Biology|January 11, 2014
Two years later: journals are not yet enforcing the ARRIVE guidelines on reporting standards for pre-clinical animal studiesDavid Baker, Katie Lidster, Ana Sottomayor, et al.
Frontiers in Neuroendocrinology|February 1, 2012
Multiple sclerosis: neuroprotective alliance of estrogen-progesterone and genderMarkus Kipp, Sandra Amor, Raphael Krauth, et al.
Drug Discovery Today|June 9, 2004
Evaluating the validity of animal models for research into therapies for immune-based disordersBert A 't Hart, Sandra Amor, Margreet Jonker
Multiple Sclerosis and Related Disorders|September 21, 2016
CD20 therapies in multiple sclerosis and experimental autoimmune encephalomyelitis - Targeting T or B cells?Marie Colombe Agahozo, Laura Peferoen, David Baker, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2011
Comment on "Chaperone activity of α B-crystallin is responsible for its incorrect assignment as an autoantigen in multiple sclerosis"Johannes M van Noort, Sandra Amor, Jeffrey J Bajramovic
Pageof 15